According to our (Global Info Research) latest study, the global Radiation Therapy Immobilization Devices market size was valued at US$ 381 million in 2025 and is forecast to a readjusted size of US$ 679 million by 2032 with a CAGR of 8.9% during review period.
Radiation Therapy Immobilization Devices are medical devices used during radiation therapy. Their primary function is to keep a patient's body in a fixed position and posture throughout the radiation treatment process. They are essential tools used in radiation therapy to ensure that radiation is delivered precisely to the targeted area while minimizing exposure to surrounding healthy tissues.
Key Findings
Radiation Therapy Immobilization Devices reached an estimated global output of 5.36 million units in 2025
The average price of Radiation Therapy Immobilization Devices was approximately US$69 per unit in 2025
Positioning films, positioning bags and positioning pads form the volume base of the Radiation Therapy Immobilization Devices market
Hospitals are the primary application market for Radiation Therapy Immobilization Devices, followed by radiology centers
The supply landscape of Radiation Therapy Immobilization Devices combines established international specialists and an expanding group of China-based manufacturers
Market Trends
The radiotherapy industry is moving toward higher precision and higher dose per fraction, as image-guided radiotherapy, stereotactic body radiotherapy and proton therapy expand in clinical use; these modalities impose tighter setup tolerances and require more reproducible patient positioning, directly raising clinical requirements for immobilization devices. Product development is shifting from standardized toward patient-specific solutions, with thermoplastic positioning films molded to individual anatomy and vacuum positioning bags adapted to body contours becoming mainstream practice for complex treatment sites. Devices are also increasingly required to be compatible with CT, MR and PET-CT imaging and with adaptive radiotherapy workflows, prompting continuous upgrades in materials, structure and positioning aids. Meanwhile, the expansion of radiotherapy capacity in emerging markets and the emergence of standalone radiology and radiotherapy centers tend to generate demand for standardized positioning packages. Overall, the industry is evolving from basic fixation toward precision, personalization and integration with the broader radiation oncology workflow.
Market Dynamics
Drivers
The growth of radiation therapy immobilization devices is mainly driven by the sustained expansion of radiotherapy utilization in oncology and the rising share of precision radiotherapy modalities that demand strict positioning accuracy and reproducibility. Because positioning films, positioning bags and positioning pads are consumables used per patient, demand recurs continuously and is closely tied to treatment volume. The installation and upgrade of linear accelerators, stereotactic systems and proton therapy facilities generate accompanying demand for positioning frames and accessories. In addition, the ongoing build-out of radiotherapy capacity in emerging regions and the establishment of new treatment centers broaden the industry's customer base.
Restraints
Market growth is constrained by price pressure in public healthcare procurement, which limits the uptake of higher-priced, upgraded products in budget-sensitive settings. The consumables segment faces intense competition and comparatively thin margins, while fluctuations in polymer and metal raw material costs squeeze manufacturers' profitability. Demand for immobilization devices is also closely linked to radiotherapy equipment installation and replacement cycles, so procurement can be delayed by budget approvals and by medical device registration and quality requirements that differ across markets.
Opportunities
Future opportunities mainly lie in product upgrades toward patient-specific and imaging-compatible solutions, including high-performance thermoplastic masks and vacuum positioning bags designed for stereotactic and adaptive radiotherapy. The expansion of radiotherapy capacity in emerging markets and the growth of standalone radiology centers create incremental demand for standardized positioning packages and local supply. Vendors may also capture higher value by integrating positioning products with treatment planning workflows, building recurring consumable revenue, and entering new application areas such as proton therapy and pediatric radiotherapy.
Challenges
The industry faces intensifying competition as more regional suppliers enter the consumables market, increasing price pressure and the risk of product homogenization. Manufacturers must comply with evolving medical device regulations and quality standards across regions, which raises compliance costs and lengthens time to market. Demand may also fluctuate with healthcare budget cycles and the pace of radiotherapy equipment investment, while the technical differentiation of positioning products remains more limited than in other segments of the radiation oncology technology chain.
Industry Chain Analysis
The industry chain of radiation therapy immobilization devices consists of upstream raw materials, midstream manufacturing and downstream clinical application. Upstream supply mainly involves thermoplastic polymers, foam and vacuum materials, carbon fiber composites and metal components, where material performance and cost stability directly affect product quality and margin levels. Midstream covers product design, molding and thermoforming, vacuum bag sealing, precision assembly, quality control and regulatory registration, and competitiveness is largely determined by manufacturing consistency, clinical validation capability and compliance strength. Downstream demand comes from hospital radiotherapy departments and radiology centers, as well as radiotherapy equipment vendors that bundle positioning products with their systems; the end users are radiation oncologists, medical physicists and radiation therapists, who place the highest value on setup accuracy, reproducibility and operational efficiency.
Value creation progresses from material performance to manufacturing precision and ultimately to clinical accuracy and treatment safety. In terms of cost and profit structure, consumable products generate continuous demand but face evident price competition in standardized specifications, while patient-specific and imaging-compatible products, which require greater clinical and technical input, typically retain higher value and offer more pricing room.
Segment Insights
Among the product segments of radiation therapy immobilization devices, positioning film is the most widely used consumable category. Typically thermoformed from low-temperature thermoplastic materials, positioning film is molded to individual patient anatomy and is mainly applied to head, head-and-neck and thoracic immobilization; its softening temperature generally falls in the 60–70 °C range, and its shape memory and repeat-positioning performance make it a per-patient customized product whose usage rises continuously with treatment volume. Positioning bag, a vacuum-based cushion that conforms to the patient's body contour, is mainly used for pelvic, abdominal and whole-body positioning; with a relatively simple structure and intense price competition, it belongs to the high-volume basic consumable segment. Fixing frame is a durable equipment-type product, usually made of lightweight, high-stiffness, radiation-transparent carbon fiber materials, and is often combined with headrests, knee supports and other accessories and integrated with treatment table systems; it carries a higher unit value and a longer procurement cycle, and its demand is closely related to radiotherapy equipment installation and upgrades. Overall, positioning films, bags and pads form the volume base of the industry, while fixing frames carry higher per-unit value; patient-specific molding, improved imaging compatibility and applications in high-precision scenarios such as stereotactic radiotherapy are the main upgrading directions.
Downstream Market Opportunities
Hospitals are the largest downstream market for radiation therapy immobilization devices, with radiotherapy departments of general hospitals and cancer hospitals delivering the majority of radiotherapy services. In this channel, devices are used in simulation, daily treatment positioning and position verification, and purchasing decisions mainly focus on setup accuracy and reproducibility, compatibility with linear accelerators, ease of operation and consumable cost; for suppliers, opportunities lie in recurring consumable replacement, supporting orders that follow radiotherapy equipment procurement, and upgrades toward high-precision, patient-specific products. Radiology centers, including standalone radiotherapy centers and imaging-oriented radiation facilities, represent an emerging downstream channel that typically procures standardized, turnkey positioning packages and emphasizes supply stability, service responsiveness and local supply, so new center construction and regional expansion provide incremental business for manufacturers. In addition, pediatric radiotherapy has specific requirements for product sizing and patient comfort, while proton therapy centers impose strict positioning accuracy demands that drive demand for advanced immobilization products, both constituting emerging application directions worth attention.
Regional Insights
From the perspective of radiotherapy equipment penetration and clinical practice maturity, North America and Europe have the most well-established radiotherapy services, and demand for radiation therapy immobilization devices there is mainly driven by steady renewal and upgrades toward precision modalities. The Asia-Pacific region, including China, is in a stage of continuous radiotherapy capacity building, where the expansion of hospital radiotherapy departments and the establishment of new treatment centers create incremental demand; this market simultaneously needs imported high-precision products and leaves room for locally supplied, cost-competitive alternatives. Judging from the enterprise composition of the global supply landscape, the notable number of China-based manufacturers indicates that China is not only an important demand market but also a production base serving both domestic and export demand. Differences in healthcare budgets, reimbursement policies and device registration requirements across markets are expected to shape the pace of demand release and the product mix in each region.
Competitive Landscape Analysis
The competitive landscape of the radiation therapy immobilization device market is characterized by the coexistence of international specialized manufacturers and regional suppliers. Established international players including Orfit Industries, CQ Medical, CDR Systems, Candor Denmark, Alcare and IZI Medical Products focus on radiotherapy positioning and related accessory categories, building clinical credibility and channel advantages through long-term cooperation with radiotherapy institutions; Orfit Industries is particularly noted for its long-standing expertise in thermoplastic positioning products. Radiotherapy equipment and software platform vendors such as Elekta and Brainlab incorporate positioning products into their overall radiation oncology solutions and sell them through equipment and software channels. Oncology Systems Limited and other regional distributors extend market coverage through equipment and accessory supply. China-based manufacturers, including Klarity, Renfumed, Tengfeiyu, ComeBetter and Yabin Medical, mainly compete on cost efficiency, localized service and flexible supply while serving both domestic demand and export markets, and they continue to strengthen their product portfolios and quality systems. Overall, competition is most intense in the standardized consumables segment where price and service are the key competitive factors, while patient-specific and imaging-compatible products offer greater room for differentiation.
Report Scope
This report is a detailed and comprehensive analysis for global Radiation Therapy Immobilization Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radiation Therapy Immobilization Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Radiation Therapy Immobilization Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Radiation Therapy Immobilization Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Radiation Therapy Immobilization Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiation Therapy Immobilization Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiation Therapy Immobilization Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CQ Medical, Orfit Industries, Elekta, Klarity, CDR Systems, Alcare, Candor Denmark, IZI Medical Products, Renfumed, Tengfeiyu, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Radiation Therapy Immobilization Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Fixing Frame
Positioning Film
Positioning Bag
Positioning Pad
Others
Market segment by Fixed Area
Head and Neck Immobilization Devices
Thoracic and Abdominal Immobilization Devices
Pelvic Immobilization Devices
Extremity Immobilization Devices
Multi-region and Whole-body Immobilization Devices
Market segment by Weight
Weight <1kg
Weight 1-5kg
Weight >5kg
Market segment by Application
Hospital
Radiology Center
Others
Major players covered
CQ Medical
Orfit Industries
Elekta
Klarity
CDR Systems
Alcare
Candor Denmark
IZI Medical Products
Renfumed
Tengfeiyu
Brainlab
Oncology Systems Limited
ComeBetter
Yabin Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Radiation Therapy Immobilization Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiation Therapy Immobilization Devices, with price, sales quantity, revenue, and global market share of Radiation Therapy Immobilization Devices from 2021 to 2026.
Chapter 3, the Radiation Therapy Immobilization Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiation Therapy Immobilization Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Radiation Therapy Immobilization Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiation Therapy Immobilization Devices.
Chapter 14 and 15, to describe Radiation Therapy Immobilization Devices sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Radiation Therapy Immobilization Devices. Industry analysis & Market Report on Radiation Therapy Immobilization Devices is a syndicated market report, published as Global Radiation Therapy Immobilization Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Radiation Therapy Immobilization Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.